by Vandana Singh | Feb 2, 2026 | General
Twist Bioscience Corporation (NASDAQ:TWST) on Monday posted first-quarter 2026 results of a loss of 50 cents per share, in line with the Wall Street expectations. Sales reached $103.70 million, up 17% year over year, beating the consensus of $102.72 million, and the...
by Bibhu Pattnaik | Feb 2, 2026 | General
Software giant, Oracle Corporation (NYSE:ORCL), has revealed that it is planning to raise between $45 billion and $50 billion in 2026 for the expansion of its cloud infrastructure capacity. • Oracle stock is trading near recent lows. What should traders watch with...
by Vandana Singh | Feb 2, 2026 | General
Avalo Therapeutics Inc.’s (NASDAQ:AVTX) completed enrollment of the Phase 2 LOTUS trial of AVTX-009, the company’s lead drug candidate. The global trial includes approximately 250 adults with moderate to severe hidradenitis suppurativa to evaluate the efficacy and...
by Parshwa Turakhiya | Feb 2, 2026 | General
Bitcoin (CRYPTO: BTC), Ethereum (CRYPTO: ETH), and XRP (CRYPTO: XRP) continue bleeding lower, but Hyperliquid (CRYPTO: HYPE) surged 10% after the decentralized exchange unveiled plans to add prediction markets through its HIP-4 proposal. The Prediction Markets Play...
by Vandana Singh | Feb 2, 2026 | General
On Monday, Wave Life Sciences Ltd. (NASDAQ:WVE) said it regained full rights to WVE-006 from GSK Plc (NYSE:GSK). The update follows agreement with GSK, whose respiratory portfolio is focused on large-scale diseases, that Wave is well placed to advance the WVE-006...
Recent Comments